$13.89
-0.110 (-0.786%)
At Close: Jul 31, 2026
Bayer AG (BAYZF) CEO Werner Baumann on Q4 2021 Results - Earnings Call Transcript
12:39pm, Tuesday, 01'st Mar 2022
Bayer AG (BAYZF) CEO Werner Baumann on Q4 2021 Results - Earnings Call Transcript
Bayer Earnings, Revenue Beat in Q1 By Investing.com
11:33am, Tuesday, 01'st Mar 2022 Investing.com
Bayer Earnings, Revenue Beat in Q1
Bayer (BAYRY) Earnings & Revenues Surpass Estimates in Q4
10:44am, Tuesday, 01'st Mar 2022
Bayer (BAYRY) beats estimates for both earnings and revenues in the fourth quarter of 2021.
Bayer swings back to full-year profit in 2021
07:40am, Tuesday, 01'st Mar 2022 UrduPoint
German chemicals and pharmaceuticals giant Bayer said Tuesday that it was back in the black in 2021, thanks primarily to a strong performance of its agrochemicals division. Its return to profit came after the coronavirus pandemic and litigation costs had pushed it into a massive loss a year earlier. ..
Bayer predicts full-year profit growth on demand from farmers By Reuters
07:22am, Tuesday, 01'st Mar 2022 Investing.com
Bayer predicts full-year profit growth on demand from farmers
Bayer predicts full-year profit growth on demand from farmers
07:09am, Tuesday, 01'st Mar 2022 FX Empire
FRANKFURT (Reuters) – German diversified group Bayer said on Tuesday it was aiming for a 7% increase in adjusted core earnings at constant foreign exchange rates this year as an upswing in demand for its seeds and pesticides is partly offset by investments in new genetic treatment technologies.
Bayer 4Q Sales EUR11.12B
06:59am, Tuesday, 01'st Mar 2022 MarketWatch
Corrections & Amplifications This headline was corrected at 0649 GMT. The oriiginal misstated the figure as EUR2.34B.By Cecilia Butini Bayer AG on…
Bayer predicts full-year profit growth on demand from farmers
02:22am, Tuesday, 01'st Mar 2022
German diversified group Bayer said on Tuesday it was aiming for a 7% increase in adjusted core earnings at constant foreign exchange rates this year as an upswing in demand for its seeds and pesticid
Bayer Q4 Earnings Preview
04:59pm, Monday, 28'th Feb 2022 Seeking Alpha
Bayer (OTCPK:BAYZF) is scheduled to announce Q4 earnings results on Tuesday, Mar. 1, before market open.The consensus revenue estimate is $11.86B.
Cinven said near agreement to purchase Bayer''s pest control business
02:20pm, Sunday, 27'th Feb 2022 Seeking Alpha
Private equity firm Cinven is said near an agreement to Bayer AG''s (BAYZF) pest control business. Cinven won out over other investment firms for Bayer''s Environmental Science…
Customer Experience Professionals Association Expands Leadership, Research, and Professional Certification
01:00am, Saturday, 26'th Feb 2022 Benzinga
MINNEAPOLIS , Feb. 25, 2022 /PRNewswire-PRWeb/ -- The Customer Experience Professionals Association (CXPA) has announced an ambitious 2022 plan of work, supported by more than two hundred volunteers across the globe. Founded just eleven years ago, CXPA now has members in over sixty countries who share a passion for helping organizations design and deliver experiences that meet or exceed customer expectations. CXPA defines customer experience as "the perception that customers have of an organization - one that is formed based on interactions across all touchpoints, people, and technology over time." The 2022 CXPA Board of Directors includes sixteen CX professionals led by 2022 Chair Nancy Porte , CCXP, Vice Chair Tabitha Dunn , CCXP and Treasurer Amy Shioji , CCXP. Newly appointed Board members for 2022 are Anita Siassios , CCXP, Founder & Managing Director, ManagingCX Pty Ltd ( Australia ); Carolyn Galvin , CCXP, Director, Market & Competitive Intelligence, Affinity.co ( USA ); Mr. Sebastien Munar , CCXP, B2C Unit Director, Clientrika ( Peru ); Mr.
Androgen Replacement Therapy Market Is Booming Worldwide 2022-2028 | AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Plc., Eli Lilly and Company
10:32am, Friday, 25'th Feb 2022 OpenPR
Coherent Market Insights published a business research report on Androgen Replacement Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022-2028. Androgen Replacement Therapy Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages
Bayer raises peak sales estimate for prostate cancer drug after positive phase 3 data
10:33am, Friday, 18'th Feb 2022 Seeking Alpha
Bayer (BAYZF) is raising peak sales expectation for Nubeqa (darolutamide) after the drug, in combination with other therapies, increased overall survival ((OS)) in patients with…
Bayer’s Nubeqa drug significantly prolongs survival in prostate cancer trial
10:16pm, Thursday, 17'th Feb 2022 SABC News
Bayer said a therapy mix including its Nubeqa drug was shown to significantly prolong the lives of men suffering from metastatic prostate cancer in a clinical study, underpinning prospects for the drug to become a major sales driver. The post Bayer’s Nubeqa drug significantly prolongs survival in prostate cancer trial appeared first on SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa''s news leader. .
Bayer rolls out short corn variety tolerant of weather extremes By Reuters
06:17pm, Thursday, 17'th Feb 2022 State Of Press
© Reuters. By Karl Plume (Reuters) – Global farm chemicals and seeds maker Bayer (OTC:) will launch a corn variety in the United States next year that it says will better tolerate heavy winds associated with climate change, estimating future sales in North America as high as 1 billion euros. The corn, which grows one-third …
Sign In
Buy BAYRY